Skip to content

The effect of zoledronic acid on bone turnover and metabolic disorder in patients with osteoporosis with type 2 diabetes mellitus

The effect of zoledronic acid on bone turnover and metabolic disorder in patients with osteoporosis with type 2 diabetes mellitus: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017906
Enrollment
Unknown
Registered
2018-08-21
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis and Type 2 diabetes

Interventions

Group 1:zoledronic acid injection
Group 2:caltrate D

Sponsors

Ninth People 's Hospital, Affiliated to Shanghai Jiaotong University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Male or postmenopausal women aged 45-70 years; 2. According to the 1994 WHO diagnostic criteria for osteoporosis, diagnosed as osteoporosis or lower bone density; 3. The diagnosis criteria of type 2 diabetes mellitus are combined with the medical history, clinical manifestation and signs; 4. Can follow the doctor's advice on time medication; 5. Sign Informed consent

Exclusion criteria

Exclusion criteria: 1. Patients who have used other bisphosphonates in the last 2 years; 2. Patients who are using hormone replacement therapy; 3. Secondary osteoporosis and osteomalacia; 4. Severe glycemic Control (HbA1c>9.0%); 5. The recent operation of the Department of Stomatology; 6. Secondary hypertension and severe triglyceride (>5.6 mmol/l); 7. Severe hepatic and renal insufficiency; 8. Persons suffering from severe heart, blood, mental and neurological disorders; 9. Active cancer and other serious diseases.

Design outcomes

Primary

MeasureTime frame
bone turnover metabolites;

Secondary

MeasureTime frame
metabolic disorder;bone density;bone fracture;SF-36;

Countries

China

Contacts

Public ContactBoren Jiang

Ninth People 's Hospital, Affiliated to Shanghai Jiaotong University, School of Medicine

xyzjiang@aliyun.com+86 18019790671

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026